Browsing by Subject
Now showing items 1-2 of 2
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
(American Society of Clinical Oncology, 2023-04-10)
Now showing items 1-2 of 2